Showing results for Cancer

IU School of Medicine research team discovers drug target, pathway for treating muscle and fat wasting in pancreatic cancer patients

A team of all Indiana University School of Medicine researchers have discovered a novel drug target to treat involuntary muscle and fat wasting, known as cachexia, in people with pancreatic cancer.

IU School of Medicine | Jun 29, 2021

IU School of Medicine researchers develop computer program to predict whether patients could be at high risk for Alzheimer’s and cancer

A group of researchers from Indiana University School of Medicine and Indiana University Bloomington have developed a program called Multi-Omics Graph cOnvolutional NETworks (MOGONET) that integrates omics data – such as DNA, RNA and proteins – to help researchers get a comprehensive understanding of human diseases. MOGONET can identify potential biomarkers for Alzheimer’s disease and cancers from the various omics data to predict which individuals may be at higher risk.

IU School of Medicine | Jun 23, 2021

Cancer center joins call for urgent action to get cancer-preventing HPV vaccination back on track

Indiana University Melvin and Bren Simon Comprehensive Cancer Center has joined National Cancer Institute (NCI)-designated cancer centers and other organizations in a joint statement urging the nation’s health care systems, physicians, parents and children, and young adults to get the human papillomavirus (HPV) vaccination back on track.

IU School of Medicine | May 25, 2021

Cancer researchers study cognitive dysfunction after chemotherapy

Cancer researchers at Indiana University and the University of Pittsburgh received a five-year, $3 million grant from the National Cancer Institute (NCI) to study cognitive dysfunction after chemotherapy.

IU School of Medicine | May 04, 2021

IU School of Medicine researchers discover gamechanger combination drug for triple negative breast cancer

A team of Indiana University School of Medicine researchers has developed a novel antibody-drug conjugate for treating triple negative breast cancer.

IU School of Medicine | Feb 23, 2021

IU cancer center researchers discover how breast cancer cells hide from immune attack

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified how breast cancer cells hide from immune cells to stay alive. The discovery could lead to better immunotherapy treatment for patients.

IU School of Medicine | Jan 26, 2021

IU cancer center findings could reduce treatment-related complication for blood cancer patients

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center published promising findings today in the New England Journal of Medicine on preventing a common complication to lifesaving blood stem cell transplantation in leukemia.

IU School of Medicine | Jan 07, 2021

IU School of Medicine researchers publish first scientific article dedicated to Tyler Trent’s donated tumors, his legacy

Researchers at Indiana University School of Medicine have published their work about a specific type of childhood cancer in the peer-reviewed, international oncology journal, Cancers. This research involves a combination therapy that significantly slows tumor growth in models, which includes a model established from cells taken from tumors donated by Tyler Trent.

IU School of Medicine | Dec 01, 2020

Harikrishna Nakshatri IU Simon Cancer Center

Cancer center researcher receives $1.3 million grant to improve breast cancer treatment for Black women

An Indiana University Melvin and Bren Simon Comprehensive Cancer Center researcher is identifying the unique biology that may make Black women more susceptible to aggressive breast cancer.

IU School of Medicine | Nov 18, 2020

John Turchi National Cancer Institute grant lung cancer

IU researcher receives $2.9 million for work improving effectiveness in lung cancer radiation therapy

An Indiana University Melvin and Bren Simon Comprehensive Cancer Center researcher has been awarded a five-year, $2.9 million grant from the National Cancer Institute to develop a drug that could make radiation therapy far more effective.

IU School of Medicine | Nov 10, 2020